Finzati - Logo
INMD logo

InMode Ltd.

INMDMedical - Devices
$14.91
+0.07 (+0.47%)
Current price
EarningsLatest report: Mar 31, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$953.38M
Growth
35.0%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 25.3%Positive revenue growth · 6.9%Positive free cash flow · 1.3Consistent free cash flow · 5/5Reasonable earnings multiple · 10.12
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 6, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$14.91
Change0.47%
Shares Out63.94M
Market Cap$953.38M
Enterprise Value$416.22M
52W Range12.72 - 16.74
Beta1.87
P/E10.93
P/S2.54
P/B1.44
P/FCF10.52
EV/Sales1.11

Investment DNA

How strong this company looks for long-term investors

76
out of 100
Business Quality
Margins, moat, returns
75/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
90/100
Why this score
Stable or improving margins · 25.3%Positive revenue growth · 6.9%Positive free cash flow · 1.3Consistent free cash flow · 5/5Reasonable earnings multiple · 10.12Manageable debt level · 0.02

Analyst view

Analyst sentiment and price target

INMD
Analyst sentiment
Based on 11 analyst votes · 2026-09-05
73/100
Bullish
Bullish
5
Hold
6
Bearish
0
Price Target
2026-08-05
Low
$17.00
Mean
$18.00
Median
$18.00
High
$19.00

Company Overview

IPO: 8/8/2019
Industry: Medical - Devices
P/B i: 1.44
Debt / Equity i: 0.02
Operating Margin: 23.05%
Net Margin: 25.33%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.02
Current Ratio: 9.88
Quick Ratio: 8.61
Status: Good

Insider Transactions

Recent executive and insider activity

Ron Hadar
Transaction: 07/30/2026
BUY
Change
+2,000
Price
Not reported
Filing
07/30/2026
Type
BUY
Nass Shlomo
Transaction: 07/30/2026
BUY
Change
+2,000
Price
Not reported
Filing
07/30/2026
Type
BUY
Kenneth Nadav
Transaction: 07/30/2026
BUY
Change
+2,000
Price
Not reported
Filing
07/30/2026
Type
BUY